Pharmaceutical Commerce - March/April 2013 - (Page 4)

Table of Contents 3 Editorial The war on prescription drug abuse Like the other war on drugs, there’s no end in sight 6 Op-Ed Why community oncology matters Oncology is the market for today’s pipeline products. Here’s why the community setting needs to be preserved as a primary site of care to administer those products Managing the specialty pharmacy channel’s evolution Focusing pharma marketing on ‘headroom’ In the race to improve product performance, not enough attention is paid to ‘who’s actually going to switch?’ 8 Top News Leading EHR vendor, athenahealth, will buy Epocrates, mobile drug info provider, for $293 million Step is one of the first toward consolidation of electronic health providers and information publishers Outcomes research will get a boost from an Optum/Mayo Clinic collaboration Optum Labs will run analytics on millions of claims and clinical records to find improved outcomes Social media and medication adherence: Theory and promise are way ahead of results Lack of quantitative clinical results and FDA regulatory uncertainty leave unclear benefits for this $300-billion problem Compounding pharmacy problems fester as death toll mounts and FDA seeks new regulatory authority Distinguishing between pharmaceutical manufacturing and pharmacy compounding remains a policy conflict Delivering samples in bags and boxes improves overall campaign effectiveness, says Brandperx ‘Scriptbags’ and ‘Rep in a Box’ are about to be tested in pharma sample distribution 10 Business/Finance What manufacturers should anticipate when working with specialty pharmacies When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully A conversation with Lynnette Cooke, Kantar Health Life sciences clusters: the emerging markets trend Annual Jones Lang LaSalle report ranks US clusters, looks at international activity Stakeholder survey finds broad approval for copay cards Patients, physicians and pharmacists signal their support of copay cards in Alliance Life Sciences study 18 Brand Marketing & Communications Landmarks to sampling in a digitized healthcare environment The accelerating adoption of electronic health records, e-prescribing and mobile technologies will change the conventions of sample distribution Pharma struggles to manage the complexity of its Patient Assistance Programs While awaiting the effects of the Affordable Care Act on PAPs, industry and its service providers wrestle with conflicting priorities Remedy Media launches wellness site with UC Berkeley Web design is tailored to tablets, with scrolling screens and ‘native content’ for advertisers Doximity.com, a physician-only website, is drawing 5,000 new members monthly Site puts an emphasis on effective referrals and collaboration among physicians 24 Supply Chain/Logistics 2013 HDMA Distribution Management Conference International collaboration emerges as a focus VOL. 8, NO. 2 Founder and Editor in Chief Nicholas Basta, 718 282 6112 nbasta@pharmaceuticalcommerce.com Contributing Editors Lena Anthony, F.J. Quinn, Bob Sperber, Suzanne Shelley, Peggy Wright Editorial Board Jeffrey Berkowitz, Walgreens Richard Carlson, Blue Fin Group Liz Coyle, IMS Health Adam Fein, Pembroke Consulting Rich Minoff, 1 Global Partners Mark Seitz, Eli Lilly & Co. Robert Zachow, Bracco Diagnostics Advertising Sales Senior Vice President and Publisher Clifford P. Tallman, Jr., 203 831 0771 ctallman@pharmaceuticalcommerce.com UPS Healthcare Logistics adds 800,000 sq. ft. to its North American distribution centers Next addition is ‘already being planned’ says divisional VP, Bill Hook New England Vince Cavaseno, 617 232 2000 vcavaseno@pharmaceuticalcommerce.com Jody Estabrook, 774 283 4528 jestabrook@pharmaceuticalcommerce.com Of 58 new-drug announcements from FDA in 2012, 22 (38%) are cold chain products Proportion of cold chain products continues to grow in the biopharma inventory Midwest David Gerchen, 314 878 3939 dgerchen@pharmacueticalcommerce.com Southeast Cathy Williams, 703 587 7142 cwilliams@pharmaceuticalcommerce.com Cardinal Health to buy AssuraMed, leading home-health supplier West Richard Ayer, 949 366 9089 rayer@pharmaceuticalcommerce.com 28 Information Technology Sales automation tools make strides in addressing industry needs The near-takeover of detailing with the Apple iPad has created a springboard for new applications Online service that provides healthcare guidance, including writing prescriptions, sees dramatic growth Virtuwell, operated by a MN healthcare provider, has expanded to three states 30 Manufacturing & Packaging Transdermal drug delivery looks for new frontiers Microneedles and ‘active’ patches extend the reach of transdermal applications Can pharmacy automation change the drug-compounding market dynamics? Supplier of injectable-drug dispensing system sees new opportunities 34 Legal & Regulatory Criminal investigations for counterfeit, diverted drugs skyrocketed in 2012 Number of cases opened by FDA’s Office of Criminal Investigations (OCI) triples to 170 Advertising Production Heidi Nelson, 203 852 6570, ext. 228 hnelson@pharmaceuticalcommerce.com Circulation and Administration Senior Vice President and General Manager David Soskin, 203 831 0711 dsoskin@pharmaceuticalcommerce.com Reprints, Research and Custom Publishing David Soskin, 203 831 0711 dsoskin@pharmaceuticalcommerce.com Circulation Subscription Changes Jennifer Lee, 800 437 7456 jennifer.lee@emscirc.com Healthcare Commerce Media Corporation Pharmaceutical Commerce is published by Healthcare Commerce Media Corp. 85 Westminster Rd., Brooklyn, NY 11218. Editorial/Advertising Queries: 718 282 6112, or info@pharmaceuticalcommerce.com Copyright 2013. All rights reserved. Printed in the United States of America. Send all subscription inquiries or requests to Subscriptions, Pharmaceutical Commerce, 151 Fairchild Avenue, Plainview, NY 11808-1709, Tel: 800 437 7456. Fax: 516 908 3802 The management and editors of Pharmaceutical Commerce make every effort to publish accurate information. However, neither the management, editorial board, editors or reporters can be held liable for erroneous information. Opinions of Pharmaceutical Commerce columnists are their own, and do not necessarily represent those of employees or other contributors to Pharmaceutical Commerce. www.PharmaceuticalCommerce.com After long delay, Sunshine Act regulations are now final Industry data collection to begin Aug. 1, with a first report to CMS on March 31, 2014 Who will represent the specialty pharmacy business? As the business grows at double-digit rates, representing its interests becomes its own business opportunity 38 4 Visit our website at www.PharmaceuticalCommerce.com March | April 2013 Meetings and Editorial Index http://www.Doximity.com http://www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - March/April 2013

Pharmaceutical Commerce - March/April 2013
Editorial
Contents
Op-Ed
Top News
Business/Finance
Brand Marketing & Communications
Supply Chain/Logistics
Information Technology
Manufacturing & Packaging
Legal & Regulatory
Meetings and Editorial Index

Pharmaceutical Commerce - March/April 2013

https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com